Australia: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Reforming Australian human tissue laws: Implications for healthcare practitioners and product manufacturers

The ALRC's inquiry has the potential to modernise and unify Australia's human tissue laws.

Australia Healthcare

B

Barry Nilsson

AHPRA guidelines on medicinal cannabis

Practitioners are instructed to take additional caution and care when prescribing medicinal cannabis given its addictive properties and potential for misuse.

Australia Healthcare

B

Barry Nilsson

Woman gives birth to stranger's baby – Monash IVF's error after error causing mistrust in the industry

Reforms in IVF laws and regulations to ensure greater transparency and accountability in the IVF industry.

Australia Healthcare

B

Barry Nilsson

Governance in Agriculture

The impact of international tariffs means farmers and growers across the country are under immense pressure.

Australia Healthcare

MO

Mellor Olsson Lawyers

Guidance when Dealing with the Department of Agriculture and Food

Australia Healthcare

HL

HHG Legal Group

Biotechnology and the R&D tax incentive – current issues

Australia Healthcare

PA

Piper Alderman

Biosecurity management plans for mining and resource companies and landowners

Australia Government

CG

Cooper Grace Ward

ToolGen Incorporated v Fisher (No 2) – Lessons In Entitlement To Priority From The Australian Federal Court

DC

Davies Collison Cave

Who Knew? Australian Government's Claim To Recoup PBS Losses Unsuccessful On Appeal

Australia Litigation

DC

Davies Collison Cave

Dodgy DNA testing casts doubt on thousands of criminal convictions

Australia Criminal

SC

Sydney Criminal Lawyers

Hong Kong Drug Registration, Patent Linkage, Patent Term Extension, And Bolar Provisions – A Taste Of "One Country, Two Systems"

DC

Davies Collison Cave

Australia To Legalize The Therapeutic Use Of Psilocybine And MDMA

DC

Davies Collison Cave

International Biosimilar Market Updates

Worldwide Healthcare

GP

Goodwin Procter LLP

Near Enough Is Good Enough: Full Federal Court Of Australia Revisits Construction Of "About" In Patent Claim

HS

Herbert Smith Freehills Kramer LLP

Immigration And Australian Federal Election Campaign Promises

Australia Immigration

IL

Interstaff Immigration Agency

Insights Into Property And Debt Market

Australia Real Estate

CP

Cathro & Partners

What Happens If… You Are Faced With A Sanctions Issue And Need To Investigate? (Podcast)

Australia International

KL

Herbert Smith Freehills Kramer LLP

Introducing Cathro Clarity: Unlocking Australia's Insolvency Data

Australia Insolvency

CP

Cathro & Partners

Inside Safety Podcast Series - Episode 3, Part 1 - Director's Duties

Australia Employment

KL

Herbert Smith Freehills Kramer LLP

Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia

Pharmaceutical manufacturing group, Celgene Corporation and Celgene Pty Ltd (together, "Celgene"), and generic drug companies, Juno Pharmaceuticals ("Juno") and Natco Pharma ("Natco")...

Australia Anti-trust

BB

Bird & Bird

Pfizer Files Lawsuit In Australia To Halt Sales Of BRENZYS (Etanercept)

Last week Pfizer filed a lawsuit in a federal court of Australia against respondents Samsung Bioepis, Merck, Sharp & Dohme, Organon, and Arrow, to halt sales of their biosimilar BRENZYS (etanercept).

GP

Goodwin Procter LLP

First Things First: Full Federal Court Clarifies The Law On Patent Term Extensions

Last week, a Full Court of the Federal Court of Australia handed down two unanimous decisions on appeal, clearing up some key uncertainties in the application of Australia's patent term extension (PTE) regime.

HS

Herbert Smith Freehills Kramer LLP

Australian IPO Review 2021: Pre–IPO Capital Raises

Pre–IPO capital raisings continue to be popular with early stage, pre–profit tech businesses looking for a longer runway ahead of their ASX listing.

Australia Finance

HS

Herbert Smith Freehills Kramer LLP

Australian patent box regime one step closer: Bill introduced into Australian parliament

SF

Spruson & Ferguson

Australian patent box takes shape

BP

Bennett & Philp Lawyers

Agricultural and veterinary chemicals legislation streamlined

Australia Healthcare

HR

Holding Redlich

Prior Art In The Age Of COVID

DC

Davies Collison Cave

The Nexus Between IP And Clinical Trials: An Australian Perspective

DC

Davies Collison Cave

Diagnostic methods patentable in Australia

CC

Corrs Chambers Westgarth

Federal Government To Introduce A "Patent Box" Tax Regime In Australia

DC

Davies Collison Cave

Women In STEM 2021 – Lessons Learnt During A Pandemic With Dr Sarah McDonald

Australia Healthcare

DC

Davies Collison Cave

DCCL Resource Centre: Issue 10

DC

Davies Collison Cave

COVID-19 and the new digital clinical trial era

Australia Technology

MR

McCullough Robertson

Federal Government To Introduce A "Patent Box" Tax Regime In Australia

The Federal Government has announced that it will introduce a "patent box" tax regime from 1 July 2022 to encourage investment and innovation in Australia in the medical and biotechnology sectors.

DC

Davies Collison Cave

Women In STEM 2021 – Lessons Learnt During A Pandemic With Dr Sarah McDonald

It's no secret that 2020 was a year like no other. To mark International Women's Day 2021, DCC caught up with some of the impressive women in its network of Women in STEM, to ask them about the past 12 months...

Australia Healthcare

DC

Davies Collison Cave

DCCL Resource Centre: Issue 10

This newsletter contains helpful up-to-date resources for our clients.

DC

Davies Collison Cave

COVID-19 and the new digital clinical trial era

Digital clinical trials should be accompanied by attention to regulatory caveats, patient privacy and data protection.

Australia Technology

MR

McCullough Robertson

COVID-19 Australia: Weekly Briefing (1 June 2020)

Australia Coronavirus

CC

Clyde & Co

Pharmaceutical and life sciences advertising to healthcare professionals - guidance from the courts

The issue of advertising and when it is misleading is important for the pharmaceutical and life sciences industries.

Australia Healthcare

CC

Corrs Chambers Westgarth

Misleading And Deceptive Claims Regarding Medicare Rebates Dismissed On Appeal

In Bupa HI Pty Ltd v Chang [2019] FCAFC 180, the Federal Court considered the proper interpretation and application of the Medicare Benefits Schedule (MBS).

Australia Healthcare

D

Dentons

Advertisers Slapped With Infringement Notices For Non-Compliant Advertising Of Therapeutic Goods

Advertisers are reminded the Therapeutic Goods Advertising Code 2018 (TGAC) was recently amended by the Therapeutic Goods Amendment (Therapeutic Goods Advertising Code) Instrument 2019.

Australia Media & IT

D

Dentons

The repeal of the IP exception - competition law exposure in the pharmaceutical and life sciences sector

Any IP licensing agreement that could affect competition, should be reviewed now to ensure competition compliance.

NR

Norton Rose Fulbright Australia

Genes, genetic applications and patent eligibility: Australia continues to be a gene-patent friendly jurisdiction

SF

Spruson & Ferguson

ACCC Wins First 'Gun Jumping' Case Against Competing Life Science Companies

Australia Anti-trust

D

Dentons

Australian Regulation Banning Animal Testing For Cosmetic Products

Australia Healthcare

S

STA Law Firm

Software As A Medical Device ("SaMD") – TGA Proposes Regulatory Reform

Australia Healthcare

DC

Davies Collison Cave

Telecommunications, Media And Technology (TMT) Law Update – Volume 25

Australia Media & IT

DC

Davies Collison Cave

Competition / antitrust, the constant constraint on pharmaceuticals, healthcare and life sciences - where the action has been in 2018 and what lies ahead

Australia Anti-trust

NR

Norton Rose Fulbright Australia

Buyer Beware: Swiss-Style Patent Claims And The Australian Life Sciences Industry

D

Dentons

Navigating Continuous Disclosure In The Life Sciences Sector

Australia Commercial

D

Dentons

New Therapeutic Goods Advertising Code: What You Need To Know

Australia Media & IT

D

Dentons

How To Submit Advertising Complaints About Therapeutic Goods

Australia Media & IT

D

Dentons

EU General Data Protection (GDPR) (Regulation 2016/679) - How is this relevant to the Australian health and lifesciences sector?

Australia Healthcare

HW

Holman Webb Lawyers

Proposed Changes To The TGA Regulatory Framework For Biologicals – Capturing Autologous Cell Therapies Wihtin The ARTG

DC

Davies Collison Cave

Health law alert from Holman Webb: welcome to the April 2018 edition

Australia Healthcare

HW

Holman Webb Lawyers

The gene patent dichotomy between the US and Australia

SF

Spruson & Ferguson

New Therapeutic Goods Legislation: What You Need To Know

Australia Healthcare

D

Dentons

See more

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More